Reata Pharmaceuticals, Inc.
Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses

Last updated:

Abstract:

Disclosed herein are compounds of the formulas: as well as analogs thereof, wherein the variables are defined herein. Also provided are pharmaceutical compositions thereof. In some aspects, the compounds and compositions provided herein may be used to inhibit ROR.gamma. and/or reduce the expression of IL-17. Also provided are methods of administering compounds and composition provided herein to a patient in need thereof, for example, for the treatment or prevention of diseases or disorders associated with inflammation or autoimmune disorders. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

16 Dec 2017

Issue date:

5 Apr 2022